Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Philadelphia, Pennsylvania


Purpose:

The purpose of this study is to assess safety and tolerability of AZD1656 after single ascending oral doses in healthy male subjects


Criteria:

Inclusion Criteria: - Provision of informed consent - Clinically normal physical findings and laboratory values as judged by the investigator including negative test of Hepatitis B surface antigen, antibodies to HIV virus and antibodies to hepatitis C virus. Exclusion Criteria: - Clinically significant illness or clinically relevant trauma, as judged by the investigator, within 2 weeks before the first administration of the Investigational Product - History of psychiatric or somatic disease/condition that may interfere with the objectives of the study, as judged by the investigator


NCT ID:

NCT00726427


Primary Contact:

Study Director
Klas Malmberg, MD, PhD
AstraZeneca R&D Mölndal


Backup Contact:

N/A


Location Contact:

Philadelphia, Pennsylvania
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.